Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial

OBJECTIVE: To assess the safety and efficacy of RSLV‐132, an RNase Fc fusion protein, in a phase II randomized, double‐blind, placebo‐controlled clinical trial in patients with primary Sjögren’s syndrome (SS). METHODS: Thirty patients with primary SS were randomized to receive treatment with RSLV‐13...

Descripción completa

Detalles Bibliográficos
Autores principales: Posada, James, Valadkhan, Saba, Burge, Daniel, Davies, Kristen, Tarn, Jessica, Casement, John, Jobling, Kerry, Gallagher, Peter, Wilson, Douglas, Barone, Francesca, Fisher, Benjamin A., Ng, Wan‐Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Sjögren’s Syndrome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839752/
https://www.ncbi.nlm.nih.gov/pubmed/32798283
http://dx.doi.org/10.1002/art.41489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839752/
https://www.ncbi.nlm.nih.gov/pubmed/32798283
http://dx.doi.org/10.1002/art.41489

Ejemplares similares